522607-97-2

Upstream product

• 874-60-2 4-methyl-benzoyl chloride 
• 362600-12-2 3-C-azidomethyl-3-deoxy-1,2-O-isopropylidene-α-D-ribofuranose 
• 146035-68-9 [(3aR,5S,6R,6aR)-6-(azidomethyl)-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl]methoxy-tert-butyl-dimethylsilane 

Downstream Products

• 522607-98-3 1,2-di-O-acetyl-3-C-azidomethyl-3-deoxy-5-O-toluoyl-D-ribofuranose 
• 630105-33-8 9-(2-O-acetyl-3-C-azidomethyl-3-deoxy-5-O-toluoyl-β-D-ribofuranose)-6-chloropurine 
• 844665-61-8 9-(3-C-azidomethyl-3-deoxy-β-D-ribofuranosyl)-N⁶-(3-iodobenzyl)adenine 
• 522607-99-4 (2R,3R,4S,5S)-4-Aminomethyl-5-hydroxymethyl-2-[6-(3-iodo-benzylamino)-purin-9-yl]-tetrahydro-furan-3-ol 

Relevant academic research and scientific papers

Modeling the Adenosine Receptors: Comparison of the Binding Domains of A2A Agonists and Antagonists

A three-dimensional model of the human A2A adenosine receptor (AR) and its docked ligands was built by homology to rhodopsin and validated with site-directed mutagenesis and the synthesis of chemically complementary agonists. Different binding